type genus of the family Cancridae (同)genus Cancer
the fourth sign of the zodiac; the sun is in this sign from about June 21 to July 22 (同)Cancer the Crab, Crab
(astrology) a person who is born while the sun is in Cancer (同)Crab
a small zodiacal constellation in the northern hemisphere; between Leo and Gemini
any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream (同)malignant neoplastic disease
relating to or involving the stomach; "gastric ulcer" (同)stomachic, stomachal
PrepTutorEJDIC
〈U〉〈C〉『がん』 / 〈U〉〈C〉害悪 / 《Cancer》(星座の)カニ座
胃の,胃に発生する
English Journal
The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer.
Tsukada T, Fushida S, Harada S, Yagi Y, Kinoshita J, Oyama K, Tajima H, Fujita H, Ninomiya I, Fujimura T, Ohta T.SourceDepartment of Gastroenterological Surgery, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, Kanazawa, Ishikawa 920-8641, Japan.
International journal of oncology.Int J Oncol.2012 Aug;41(2):476-82. doi: 10.3892/ijo.2012.1490. Epub 2012 May 18.
Peritoneal dissemination is the most frequent metastatic pattern of scirrhous gastric cancer. However, despite extensive research effort, disease outcomes have not improved sufficiently. Tumor progression and metastasis result from interactions between cancer and
Usefulness of Multidisciplinary Therapy Combining Neoadjuvant Chemotherapy with S-1 plus Cisplatin and Postoperative Sequential Chemotherapy in Patients with Scirrhous Gastric Cancer.
Oshima T, Kunisaki C, Sato T, Yamada R, Fujii S, Rino Y, Masuda M, Imada T.AbstractBackground/Aims: The outcomes of patients with scirrhous gastric cancer (SGC) remain poor. We retrospectively compared outcomes according to historically different treatments for SGC and studied the therapeutic usefulness of NAC with S-1 plus cisplatin followed by postoperative sequential chemotherapy. Methodology: We studied 93 patients with SGC. Between 1995 and 2000, 29 patients did not receive NAC and were instead given conventional anti-cancer drugs. Between 2000 and 2003, 20 patients received 4 weeks of NAC with low-dose cisplatin plus 5-fluorouracil (5-FU) followed by postoperative sequential treatment with new anticancer agents (neoadjuvant low-dose FP group). Between 2003 and 2006, 44 patients received 2 courses of NAC with S-1+cisplatin followed by postoperative sequential administration of new anticancer agents (neoadjuvant S-1+cisplatin group). Response rates and overall survival were compared among the treatment groups. Results: The rates of response to NAC were 15% in the neoadjuvant low-dose FP group and 36% in the neoadjuvant S-1+cisplatin group. Overall survival was significantly longer in the neoadjuvant S-1+cisplatin group than the other groups. Conclusions: Our results suggest that multidisciplinary therapy combining NAC with S-1+cisplatin and postoperative sequential administration of new anticancer drugs is therapeutically useful in patients with SGC.
Background/Aims: The outcomes of patients with scirrhous gastric cancer (SGC) remain poor. We retrospectively compared outcomes according to historically different treatments for SGC and studied the therapeutic usefulness of NAC with S-1 plus cisplatin followed by postoperative sequential chemothera
... and their location within the stomach (cardia, corpus, or antrum). A rare subtype of stomach cancer is scirrhous carcinoma, or linitus plastica, a poorly differentiated mixture of mucin-producing carcinoma cells that infiltrates ...
Expert-reviewed information summary about the treatment of gastric cancer. ... Key Points for This Section Gastric cancer is a disease in which malignant (cancer) cells form in the lining of the stomach. Age, diet, and stomach ...